Results 21 to 30 of about 137,417 (261)

Multifunctional biomaterial platforms for blocking the fibrosis process and promoting cellular restoring effects in myocardial fibrosis therapy

Frontiers in Bioengineering and Biotechnology, 2022
Myocardial fibrosis is the result of abnormal healing after acute and chronic myocardial damage and is a direct cause of heart failure and cardiac insufficiency.
Tian Yue, Tian Yue, Shiqiang Xiong, Dezhi Zheng, Yi Wang, Pan Long, Jiali Yang, Jiali Yang, Dunzhu Danzeng, Han Gao, Xudong Wen, Xin Li, Jun Hou, Jun Hou   +13 more
doaj   +1 more source

Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy

Cardiovascular Innovations and Applications, 2021
Hypertrophic cardiomyopathy (HCM) is a type of hereditary cardiomyopathy caused by gene mutation. Its histological features include cardiomyocyte hypertrophy and disarray as well as myocardial fibrosis.
Zeyi Cheng, Miaomiao Qi, Chengyuan Zhang, Yanxia Mao   +3 more
doaj   +1 more source

Biomarkers in patients with myocardial fibrosis

Open Life Sciences, 2017
Myocardial fibrosis is observed in many cardiovascular diseases including hypertension, heart failure and cardiomyopathy. Myocardial fibrosis has been proved to be reversible and treatable only under timely intervention, which makes early detection and ...
An Zhe, Yang Guang, Zheng Haikuo, Nie Wei, Liu Guohui   +4 more
doaj   +1 more source

DIAGNOSTIC METHODS FOR MYOCARDIAL FIBROSIS

Измерение, мониторинг, управление, контроль, 2023
Background. Myocardial fibrosis is a global public health problem because it is associated with almost all forms of cardiovascular diseases. Timely detection of myocardial fibrosis is an urgent task contributing to improving the quality of patients' life
Natalia A. Serzhantova
doaj   +1 more source

Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway

Frontiers in Pharmacology, 2021
Background: Lcz696 (ARNI, angiotensin receptor–neprilysin inhibitor; sacubitril/valsartan) shows an inhibitory effect on fibrosis after myocardial infarction (MI). However, the underlying signaling mechanisms are poorly understood.
Jing Liu, Jing Liu, Xuehui Zheng, Chen Zhang, Chunmei Zhang, Peili Bu   +5 more
doaj   +1 more source

Myocardial fibrosis in athletes: Additional considerations [PDF]

Clinical Cardiology, 2020
[No abstract]
Łukasz A. Małek, Chiara Bucciarelli‐Ducci   +1 more
openaire   +4 more sources

EGCG Alleviates Obesity-Induced Myocardial Fibrosis in Rats by Enhancing Expression of SCN5A

Frontiers in Cardiovascular Medicine, 2022
ObjectObesity is an increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. Obesity could increase the risk of myocardial fibrosis. (-)-Epigallocatechin-3-gallate (
Haoan Yi, Cong Liu, Cong Liu, Jing Shi, Shuo Wang, Haoxin Zhang, Yongshu He, Jianping Tao, Shude Li, Shude Li, Renfa Zhang   +10 more
doaj   +1 more source

Myocardial fibrosis in athletes—Current perspective [PDF]

Clinical Cardiology, 2020
AbstractSeveral previous studies suggested that prolonged and extensive physical activity might lead to increased prevalence of myocardial fibrosis in athletes. The review summarizes these studies focusing on common patterns of myocardial fibrosis observed in athletes, their potential causes and significance.
Łukasz A. Małek, Chiara Bucciarelli‐Ducci   +1 more
openaire   +3 more sources

The Prognostic Role of the Left Atrium in Hypertensive Patients with HFpEF: Does Function Matter More than Structure?

Life
Background: In arterial hypertension (AH), adverse hemodynamic consequences in the left atrium (LA) are often observed. The prognostic significance of functional vs.
Artem Ovchinnikov, Alexandra Potekhina, Anastasiia Filatova, Olga Svirida, Maria Sobolevskaya, Alfiya Safiullina, Fail Ageev   +6 more
doaj   +1 more source

Hypereosinophilic syndrome and myocardial fibrosis [PDF]

Interactive CardioVascular and Thoracic Surgery, 2008
A 62-year-old man was accepted to our institution because of hypereosinophilia, severe tricuspid regurgitation and isolated right restrictive myocardiopathy, with thrombi inside the right atrium and ventricle. Based on the diagnosis of hypereosinophilic syndrome plus eosinophilic myocarditis, the patient underwent a tricuspid valve repair and ...
Manuel, Carnero-Alcázar, Fernando, Reguillo-Lacruz, Fernando, O'Connor, Enrique, Rodríguez-Hernández   +3 more
openaire   +2 more sources